Suppr超能文献

外周血干细胞动员;展望

Peripheral blood stem cell mobilization; a look ahead.

作者信息

Pelus Louis M, Broxmeyer Hal E

机构信息

Department of Microbiology & Immunology, Indiana University School of Medicine, 950 W Walnut Street, R2-301, Indianapolis, IN 46202.

出版信息

Curr Stem Cell Rep. 2018 Dec;4(4):273-281. doi: 10.1007/s40778-018-0141-9. Epub 2018 Oct 23.

Abstract

THE PURPOSE OF REVIEW

Mobilized peripheral blood is the predominant source of stem and progenitor cells for hematologic transplantation. Successful transplant requires sufficient stem cells of high enough quality to recapitulate lifelong hematopoiesis, but in some patients and normal donors, reaching critical threshold stem cell numbers are difficult to achieve. Novel strategies, particularly those offering rapid mobilization and reduced costs, remains an area of interest.This review summarizes critical scientific underpinnings in understanding the process of stem cell mobilization, with a focus on new or improved strategies for their efficient collection and engraftment.

RECENT FINDINGS

Studies are described that provide new insights into the complexity of stem cell mobilization. Agents that target new pathways such HSC egress, identify strategies to collect more potent competing HSC and new methods to optimize stem cell collection and engraftment are being evaluated.

SUMMARY

Agents and more effective strategies that directly address the current shortcomings of hematopoietic stem cell mobilization and transplantation and offer the potential to facilitate collection and expand use of mobilized stem cells have been identified.

摘要

综述目的

动员外周血是血液学移植中干细胞和祖细胞的主要来源。成功的移植需要足够数量且质量足够高的干细胞来重建终身造血功能,但在一些患者和正常供体中,达到临界阈值的干细胞数量很难实现。新的策略,尤其是那些能够实现快速动员并降低成本的策略,仍然是一个备受关注的领域。本综述总结了理解干细胞动员过程的关键科学基础,重点关注其有效采集和植入的新策略或改进策略。

最新发现

所描述的研究为干细胞动员的复杂性提供了新的见解。正在评估针对新途径(如造血干细胞流出)的药物、收集更具潜力的竞争性造血干细胞的策略以及优化干细胞采集和植入的新方法。

总结

已经确定了直接解决造血干细胞动员和移植当前缺点并有可能促进动员干细胞采集和扩大其使用的药物和更有效的策略。

相似文献

1
Peripheral blood stem cell mobilization; a look ahead.
Curr Stem Cell Rep. 2018 Dec;4(4):273-281. doi: 10.1007/s40778-018-0141-9. Epub 2018 Oct 23.
6
A Review of Advances in Hematopoietic Stem Cell Mobilization and the Potential Role of Notch2 Blockade.
Cell Transplant. 2020 Jan-Dec;29:963689720947146. doi: 10.1177/0963689720947146.
7
Hematopoietic stem cell mobilization.
Tzu Chi Med J. 2021 Oct 21;34(3):270-275. doi: 10.4103/tcmj.tcmj_98_21. eCollection 2022 Jul-Sep.
10
Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization.
Blood Rev. 2021 May;47:100771. doi: 10.1016/j.blre.2020.100771. Epub 2020 Oct 31.

引用本文的文献

1
Graft-Versus-Host Disease Mouse Models: A Clinical-Translational Perspective.
Methods Mol Biol. 2025;2907:1-56. doi: 10.1007/978-1-0716-4430-0_1.
2
Molecular gene signature of circulating stromal/stem cells.
J Hum Genet. 2025 May;70(5):275-280. doi: 10.1038/s10038-025-01322-4. Epub 2025 Mar 12.
5
Ex Vivo Expansion and Homing of Human Cord Blood Hematopoietic Stem Cells.
Adv Exp Med Biol. 2023;1442:85-104. doi: 10.1007/978-981-99-7471-9_6.
6
The quest for the holy grail: overcoming challenges in expanding human hematopoietic stem cells for clinical use.
Stem Cell Investig. 2023 Jul 11;10:15. doi: 10.21037/sci-2023-016. eCollection 2023.
7
Harvest Quality, Nucleated Cell Dose and Clinical Outcomes in Bone Marrow Transplantation: A Retrospective Study.
Transplant Cell Ther. 2023 Oct;29(10):638.e1-638.e8. doi: 10.1016/j.jtct.2023.07.003. Epub 2023 Jul 6.
8
Hematopoietic stem cells on the crossroad between purinergic signaling and innate immunity.
Purinergic Signal. 2025 Feb;21(1):3-9. doi: 10.1007/s11302-023-09943-0. Epub 2023 May 15.
10
Hematopoietic stem cell mobilization.
Tzu Chi Med J. 2021 Oct 21;34(3):270-275. doi: 10.4103/tcmj.tcmj_98_21. eCollection 2022 Jul-Sep.

本文引用的文献

2
AMD3100 ameliorates cigarette smoke-induced emphysema-like manifestations in mice.
Am J Physiol Lung Cell Mol Physiol. 2018 Sep 1;315(3):L382-L386. doi: 10.1152/ajplung.00185.2018. Epub 2018 May 10.
3
Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy.
Blood Adv. 2018 May 8;2(9):987-999. doi: 10.1182/bloodadvances.2018016451.
5
High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantation.
Oncotarget. 2017 Nov 27;8(66):110350-110357. doi: 10.18632/oncotarget.22739. eCollection 2017 Dec 15.
6
Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell.
Cell. 2018 Jan 11;172(1-2):191-204.e10. doi: 10.1016/j.cell.2017.11.003. Epub 2017 Dec 7.
7
Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells.
J Clin Invest. 2017 Dec 1;127(12):4527-4540. doi: 10.1172/JCI94687. Epub 2017 Nov 13.
8
NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma.
Bone Marrow Transplant. 2018 Feb;53(2):175-179. doi: 10.1038/bmt.2017.234. Epub 2017 Oct 23.
10
Current Use and Trends in Hematopoietic Cell Transplantation in the United States.
Biol Blood Marrow Transplant. 2017 Sep;23(9):1417-1421. doi: 10.1016/j.bbmt.2017.05.035. Epub 2017 Jun 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验